James Loerop - 31 Jan 2022 Form 3 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Signature
/s/ Mark Ballantyne, as Attorney-in-Fact
Issuer symbol
ACRS
Transactions as of
31 Jan 2022
Net transactions value
$0
Form type
3
Filing time
01 Feb 2022, 15:45:07 UTC
Previous filing
12 Jul 2021
Next filing
01 Feb 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24.1 - Power of Attorney